Traditional Chinese medicine composition for treating hysteromyoma

Abstract

The invention discloses a traditional Chinese medicine composition for treating hysteromyoma. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 6-15 parts of Chinese knotweed herb, 5-10 parts of abrus cantoniensis hance, 3-8 parts of polyporus umbellatus, 8-12 parts of conyza Canadensis, 3-5 parts of latostema ichangense H. Schroter, 10-20 parts of pepper wort herb, 4-10 parts of graperoot, 10-15 parts of fiddleleaf fig root leaf, 2-6 parts of fried spina date seeds, 10-20 parts of dianthus superbus, 8-20 parts of manis pentadactyla, 6-10 parts of lycopodium clavatum, 3-7 parts of ternate buttercup root and 10-15 parts of liquorice. By virtue of combination of the theories of traditional Chinese medicines and application of special medicine properties of traditional Chinese medicines, a plurality of traditional Chinese medicines cooperate with one another; and the traditional Chinese medicine composition can be used for treating both symptoms and root causes, has the excellent properties of reasonable combination, scientific compatibility, low cost, obvious curative effect and low possibility of recurrence, provides a reliable method for treating hysteromyoma, and is broad in market prospect and application prospect.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a traditional Chinese medicine composition for treating uterine fibroids. Background technique [0002] Uterine leiomyoma, also known as uterine leiomyoma, is the most common benign tumor of female genitalia. The incidence rate of women in childbearing period is about 25%, and it accounts for about 51.87% of all benign tumors in women. According to clinical observations, all women aged 19-55 have the disease, and it is more common with 30-45 years old. Pain and inflammatory swelling caused by uterine fibroids are common complications. Its most common clinical symptoms are: uterine bleeding, lower abdominal pain and dysmenorrhea, compression symptoms, increased vaginal secretions, anemia, and even infertility, which seriously affects women's health and daily work. May transform into a malignant tumor. [0003] The clinical treatment of uterine ...

AI Technical Summary

Problems solved by technology

[0003] The clinical treatment of uterine fibroids generally adopts hormonal drug therapy and surgical treatment. Drug treatment generally uses drugs such as mifepristone, androgen, and tripterygium glycosides. Although the uterine fibroids shrink after treatment, the side effects are large. It will affect the normal hormone secretion level in the human body, destroy the normal physiological balance of the human body, and appear different degrees of masculine characteristics. After stopping the drug, the fibroids will grow again, and it will be difficult to completely cure

Hysterectomy is currently the most widely used treatment method in surgical treatment, but hysterectomy often brings physical and psychological damage to patients, it will lead to ovarian failure and early menopause, and there will be a risk of trauma and cancer, so it is not suitable for women of childbearing age. And have other comorbidities, such as obesity, hypertension, heart disease, osteoporosis

At present, in terms of various treatment methods for this disease, surgical treatment is often the last choice, hormone therapy has large side effects, and conservative treatment is often ineffective